Cutler Group LP Immunocore Holdings PLC Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Cutler Group LP holds 4,400 shares of IMCR stock, worth $131,164. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,400
Previous 2,700
62.96%
Holding current value
$131,164
Previous $23,000
82.61%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IMCR
# of Institutions
125Shares Held
42.5MCall Options Held
79.9KPut Options Held
46.2K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.7MShares$200 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA6.62MShares$197 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$145 Million2.34% of portfolio
-
Primecap Management CO Pasadena, CA2.67MShares$79.5 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$65.2 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.31B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...